By Rebecca Melvin
New York, Sept. 22 - Tenet Healthcare Corp. priced a $300 million offering of three-year mandatory convertible preferred stock with a liquidation preference of $1,000 per share for a 7% dividend and an initial conversion premium of 20%, according to a news release.
The registered, off-the-shelf offering has a 15% greenshoe for up to an additional $45 million of preferred stock.
Goldman, Sachs & Co. is the bookrunner of the offering, with Barclays Capital Inc. serving as joint lead manager. Co-managers were Moelis & Co. and Wells Fargo Securities.
Proceeds will be used to repurchase $300 million of its outstanding 9.25% senior notes due 2015 through a privately negotiated transaction.
Dallas-based Tenet Healthcare owns and operates acute-care hospitals and provides related health care services.
Issuer: | Tenet Healthcare Corp.
|
Issue: | Convertible mandatory preferreds
|
Bookrunner: | Goldman Sachs & Co.
|
Lead manager: | Barclays Capital Inc.
|
Co-managers: | Moelis & Co., Wells Fargo Securities
|
Amount: | $300 million
|
Greenshoe: | $45 million
|
Maturity: | Oct. 1, 2012
|
Dividend: | 7%
|
Price: | Par, $1,000
|
Conversion premium: | 20%
|
Conversion price: | $7.02
|
Minimum conversion rate: | 142.4501
|
Maximum conversion rate: | 170.9402
|
Takeover protection: | Yes
|
Puts: | No
|
Pricing date: | Sept. 21
|
Settlement date: | Sept. 25
|
Stock reference price: | $5.85, close on Sept. 21
|
Stock symbol: | NYSE: THC
|
Distribution: | Registered
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.